Cargando…

New Immunotherapy Strategies in Breast Cancer

Breast cancer is the most commonly diagnosed cancer among women. Therapeutic treatments for breast cancer generally include surgery, chemotherapy, radiotherapy, endocrinotherapy and molecular targeted therapy. With the development of molecular biology, immunology and pharmacogenomics, immunotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Lin-Yu, Tang, Jie, Zhang, Cong-Min, Zeng, Wen-Jing, Yan, Han, Li, Mu-Peng, Chen, Xiao-Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295319/
https://www.ncbi.nlm.nih.gov/pubmed/28085094
http://dx.doi.org/10.3390/ijerph14010068
_version_ 1782505412028792832
author Yu, Lin-Yu
Tang, Jie
Zhang, Cong-Min
Zeng, Wen-Jing
Yan, Han
Li, Mu-Peng
Chen, Xiao-Ping
author_facet Yu, Lin-Yu
Tang, Jie
Zhang, Cong-Min
Zeng, Wen-Jing
Yan, Han
Li, Mu-Peng
Chen, Xiao-Ping
author_sort Yu, Lin-Yu
collection PubMed
description Breast cancer is the most commonly diagnosed cancer among women. Therapeutic treatments for breast cancer generally include surgery, chemotherapy, radiotherapy, endocrinotherapy and molecular targeted therapy. With the development of molecular biology, immunology and pharmacogenomics, immunotherapy becomes a promising new field in breast cancer therapies. In this review, we discussed recent progress in breast cancer immunotherapy, including cancer vaccines, bispecific antibodies, and immune checkpoint inhibitors. Several additional immunotherapy modalities in early stages of development are also highlighted. It is believed that these new immunotherapeutic strategies will ultimately change the current status of breast cancer therapies.
format Online
Article
Text
id pubmed-5295319
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-52953192017-02-07 New Immunotherapy Strategies in Breast Cancer Yu, Lin-Yu Tang, Jie Zhang, Cong-Min Zeng, Wen-Jing Yan, Han Li, Mu-Peng Chen, Xiao-Ping Int J Environ Res Public Health Review Breast cancer is the most commonly diagnosed cancer among women. Therapeutic treatments for breast cancer generally include surgery, chemotherapy, radiotherapy, endocrinotherapy and molecular targeted therapy. With the development of molecular biology, immunology and pharmacogenomics, immunotherapy becomes a promising new field in breast cancer therapies. In this review, we discussed recent progress in breast cancer immunotherapy, including cancer vaccines, bispecific antibodies, and immune checkpoint inhibitors. Several additional immunotherapy modalities in early stages of development are also highlighted. It is believed that these new immunotherapeutic strategies will ultimately change the current status of breast cancer therapies. MDPI 2017-01-12 2017-01 /pmc/articles/PMC5295319/ /pubmed/28085094 http://dx.doi.org/10.3390/ijerph14010068 Text en © 2017 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Yu, Lin-Yu
Tang, Jie
Zhang, Cong-Min
Zeng, Wen-Jing
Yan, Han
Li, Mu-Peng
Chen, Xiao-Ping
New Immunotherapy Strategies in Breast Cancer
title New Immunotherapy Strategies in Breast Cancer
title_full New Immunotherapy Strategies in Breast Cancer
title_fullStr New Immunotherapy Strategies in Breast Cancer
title_full_unstemmed New Immunotherapy Strategies in Breast Cancer
title_short New Immunotherapy Strategies in Breast Cancer
title_sort new immunotherapy strategies in breast cancer
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5295319/
https://www.ncbi.nlm.nih.gov/pubmed/28085094
http://dx.doi.org/10.3390/ijerph14010068
work_keys_str_mv AT yulinyu newimmunotherapystrategiesinbreastcancer
AT tangjie newimmunotherapystrategiesinbreastcancer
AT zhangcongmin newimmunotherapystrategiesinbreastcancer
AT zengwenjing newimmunotherapystrategiesinbreastcancer
AT yanhan newimmunotherapystrategiesinbreastcancer
AT limupeng newimmunotherapystrategiesinbreastcancer
AT chenxiaoping newimmunotherapystrategiesinbreastcancer